A “new achievement” … a promising drug for the Corona virus...

The Scottish biotechnology company ILC Therapy has announced that a unique synthetic interferon treatment, called Alphasite, is more effective in preventing the spread of coronaviruses than other commercially available drugs such as Interferon alpha2 and Interferon beta 1A.

While Covid-19 disease attempts to slow the body’s innate response to the viral infection, the Alphasite treatment has been designed to help speed up this response and prevent disease progression.

Independent research at the University of St Andrews, led by Dr. Catherine Adamson, of the School of Biology, who specializes in Viral diseasesThe superior effectiveness of Alphasite during laboratory testing against coronaviruses.

Dr. Adamson, who supervised the tests, said: “This is a very exciting development, and it appears that there is a big difference in the vital activity of subtypes of interferons against corona viruses. These differences may have important therapeutic effects for Covid-19.”

The Alphasite Therapy was invented by Professor William Stimson, Founder and Senior Scientific Director, the ILC Therapy Biotechnology Foundation.

Dr. Alan Walker, CEO of the company, welcomed the results as an important development in Combating Covid-19“This is a very positive development, as the world is preparing to face the second wave. Curative interventions are necessary for us to tame the disease,” he said.

He added, “The innate immune system acts as an immune wall against Viral infection. If we can stop the virus at certain limits, and this wall enables the adaptive immune response to be prepared for battle, and Covid-19 will not be able to progress. “

Alpha-interferons are a family of 12 natural proteins. So far, only one therapeutic subtype is used, interferon alpha2.